← Leaderboards
Phoebe Lin
Oregon Health & Science University
$3,552,686
Attributed
$3,552,686
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $525.1K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,552,686 · 2
By mechanism
R01$2,507,951 · 1
K08$1,044,735 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Holly Lallman Rosenzweig$5,424,451
- Marina Elizabeth Wolf$19,441,692
- Marina Guizzetti$8,598,193
- Timothy J. Nice$3,957,016
- Kenneth John Weekes$95,556
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessIntestinesAffectInsightSeveritiesAutoimmune DiseasesInflammatoryMicroorganismPreventT-LymphocyteUveitisAntibioticsAutoimmune UveitisPathogenesisMicrobiotaRegulatory T-LymphocyteTreatment StrategyBiological MarkersBiologicalAntigensBacteriaDietAutoimmunityAggrecan
Grant awards (10)
Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis$505,063
R01 · FY2025 · EY · contact PI
Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis$525,129
R01 · FY2024 · EY · contact PI
Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis$509,956
R01 · FY2023 · EY · contact PI
Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis$478,146
R01 · FY2022 · EY · contact PI
Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis$489,657
R01 · FY2021 · EY · contact PI
The effect of the microbiome on the development and severity of uveitis$208,947
K08 · FY2017 · EY · contact PI
The effect of the microbiome on the development and severity of uveitis$208,947
K08 · FY2016 · EY · contact PI
The effect of the microbiome on the development and severity of uveitis$208,947
K08 · FY2015 · EY · contact PI
The effect of the microbiome on the development and severity of uveitis$208,947
K08 · FY2014 · EY · contact PI
The effect of the microbiome on the development and severity of uveitis$208,947
K08 · FY2013 · EY · contact PI